Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 2, 2019Bioorganic & Medicinal ChemistryOpen Access

A scaffold replacement approach towards new sirtuin 2 inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

TSTina SeifertMMMarcus MaloTKTarja Kokkola

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Seifert et al. (2019) studied this question.

synapsesocial.com/papers/69ff9a2810d6befb25774dfahttps://doi.org/10.1016/j.bmc.2019.115231
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sirtuins at the crossroads of stemness, aging, and cancer2017 · 196 citations
  2. 2Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders2016 · 259 citations
  3. 33-Alkylamino-4<i>H</i>-1,2,4-benzothiadiazine 1,1-Dioxides as ATP-Sensitive Potassium Channel Openers:  Effect of 6,7-Disubstitution on Potency and Tissue Selectivity2005 · 40 citations
  4. 4Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors2012 · 148 citations